DE2313221A1 - Kuenstliche gelenkschmiere und verfahren zu deren herstellung - Google Patents
Kuenstliche gelenkschmiere und verfahren zu deren herstellungInfo
- Publication number
- DE2313221A1 DE2313221A1 DE2313221A DE2313221A DE2313221A1 DE 2313221 A1 DE2313221 A1 DE 2313221A1 DE 2313221 A DE2313221 A DE 2313221A DE 2313221 A DE2313221 A DE 2313221A DE 2313221 A1 DE2313221 A1 DE 2313221A1
- Authority
- DE
- Germany
- Prior art keywords
- sodium
- concentration
- carboxymethyl cellulose
- synovial fluid
- sodium carboxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 238000005461 lubrication Methods 0.000 title description 3
- 210000001179 synovial fluid Anatomy 0.000 claims description 26
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 24
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 23
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 23
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 23
- 235000002639 sodium chloride Nutrition 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 210000002381 plasma Anatomy 0.000 claims description 6
- 239000004599 antimicrobial Substances 0.000 claims description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 210000004127 vitreous body Anatomy 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 210000001742 aqueous humor Anatomy 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims 2
- 235000019797 dipotassium phosphate Nutrition 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960002216 methylparaben Drugs 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 description 9
- 235000010980 cellulose Nutrition 0.000 description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 229920001448 anionic polyelectrolyte Polymers 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 239000003834 purity and quality standard Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00235311A US3830910A (en) | 1972-03-16 | 1972-03-16 | Pseudo-synovial plastic body fluids and method of preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2313221A1 true DE2313221A1 (de) | 1973-09-20 |
Family
ID=22884974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2313221A Pending DE2313221A1 (de) | 1972-03-16 | 1973-03-16 | Kuenstliche gelenkschmiere und verfahren zu deren herstellung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3830910A (enExample) |
| JP (1) | JPS49417A (enExample) |
| AU (1) | AU475354B2 (enExample) |
| BE (1) | BE796883A (enExample) |
| CA (1) | CA1011251A (enExample) |
| DE (1) | DE2313221A1 (enExample) |
| FR (1) | FR2181824B1 (enExample) |
| GB (1) | GB1391577A (enExample) |
| IE (1) | IE37384B1 (enExample) |
| NL (1) | NL7303596A (enExample) |
| SE (1) | SE425143B (enExample) |
| ZA (1) | ZA731754B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013076271A1 (de) * | 2011-11-24 | 2013-05-30 | Von Foerster Goetz | Synthetisches schmiermittel zur verwendung als synovialflüssigkeitsersatz |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4154822A (en) * | 1976-08-02 | 1979-05-15 | The University Of Chicago | Polysaccharide for enhancement of cardiac output |
| US5466680A (en) * | 1992-03-26 | 1995-11-14 | Cytologics, Inc. | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| JPH06248023A (ja) * | 1993-02-26 | 1994-09-06 | Shinnakamura Kagaku Kogyo Kk | 高分子化合物および帯電防止剤 |
| ITMI20091969A1 (it) * | 2009-11-11 | 2011-05-12 | Claudia Battaglino | Composizione oftalmica |
-
1972
- 1972-03-16 US US00235311A patent/US3830910A/en not_active Expired - Lifetime
-
1973
- 1973-03-06 CA CA165,323A patent/CA1011251A/en not_active Expired
- 1973-03-08 IE IE377/73A patent/IE37384B1/xx unknown
- 1973-03-08 GB GB1135273A patent/GB1391577A/en not_active Expired
- 1973-03-13 ZA ZA731754A patent/ZA731754B/xx unknown
- 1973-03-15 AU AU53312/73A patent/AU475354B2/en not_active Expired
- 1973-03-15 SE SE7303611A patent/SE425143B/xx unknown
- 1973-03-15 NL NL7303596A patent/NL7303596A/xx not_active Application Discontinuation
- 1973-03-15 FR FR7309303A patent/FR2181824B1/fr not_active Expired
- 1973-03-16 DE DE2313221A patent/DE2313221A1/de active Pending
- 1973-03-16 BE BE128884A patent/BE796883A/xx unknown
- 1973-03-16 JP JP48030162A patent/JPS49417A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013076271A1 (de) * | 2011-11-24 | 2013-05-30 | Von Foerster Goetz | Synthetisches schmiermittel zur verwendung als synovialflüssigkeitsersatz |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2181824A1 (enExample) | 1973-12-07 |
| BE796883A (fr) | 1973-07-16 |
| AU475354B2 (en) | 1976-08-19 |
| AU5331273A (en) | 1974-09-19 |
| GB1391577A (en) | 1975-04-23 |
| ZA731754B (en) | 1973-12-19 |
| US3830910A (en) | 1974-08-20 |
| NL7303596A (enExample) | 1973-09-18 |
| FR2181824B1 (enExample) | 1976-09-03 |
| JPS49417A (enExample) | 1974-01-05 |
| IE37384B1 (en) | 1977-07-06 |
| CA1011251A (en) | 1977-05-31 |
| SE425143B (sv) | 1982-09-06 |
| IE37384L (en) | 1973-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69306114T2 (de) | Verwendung von in situ modifikation von alginat zur vorbeugung von gewebeadhäsion | |
| DE69629795T2 (de) | Verfahren zur Herstellung von Gegenständen aus einem regenerierte Chitin-Chitosan enthaltenden Material und erhaltene Gegenstände | |
| DE3546811C2 (enExample) | ||
| DE69903351T3 (de) | Vernetzte hyaluronsäure und ihre medizinischen verwendungen | |
| DE69429522T2 (de) | Injizierbare zusammensetzungen zur vergrösserung von weichgewebe | |
| US3767437A (en) | Phosthetic structures derived from collagen | |
| DE60103894T2 (de) | Sprühfähige Wundversorgungszusammensetzungen | |
| EP0950420A2 (de) | Tricalciumphosphathaltige Biozementpasten mit Kohäsionspromotoren | |
| DE69212203T2 (de) | Intrakorporale injizierbare Zusammensetzung zum Implantieren von hochkonzentriertem vernetzten Atelokollagen | |
| DE69327142T2 (de) | Artikel mit einem Überzug mit reibungsreduzierenden Eigenschaften im Nasszustand, sowie ein Verfahren zur Herstellung dieses überzogenen Artikels | |
| DE60223930T2 (de) | Antibakterieller wundverband | |
| DE69432701T2 (de) | Flüssige Suspension von cellulose-haltigen Polysacchariden für Pflegemittel und für Haushaltsreinigungsmittel | |
| DE4303415C2 (de) | Emulsion enthaltend Chitosan | |
| DE1925868A1 (de) | Alkalimetall-aluminosilikate,Verfahren zu ihrer Herstellung sowie Massen daraus | |
| CH642669A5 (de) | Wasserloesliches guarprodukt und verfahren zu dessen herstellung. | |
| DE2653244A1 (de) | Frisch-luft-gel | |
| DE2313221A1 (de) | Kuenstliche gelenkschmiere und verfahren zu deren herstellung | |
| DE69931541T2 (de) | Calciumphosphatzement | |
| DE69822285T2 (de) | Verfahren zur Herstellung von vernetzter Hyaluronsäure | |
| DE2022498C3 (de) | Geschlossener, dreidimensionaler künstlicher Knorpel- oder Knochenersatzkörper und Verfahren zu seiner Herstellung | |
| DE832032C (de) | Schmierfett | |
| EP2170961A1 (de) | Hyaluronsäuredispersion, herstellung und anwendung | |
| DE69815055T2 (de) | Polyurethan-Stützverbände mit kontrolliertem Haftvermögen | |
| DE2818670A1 (de) | Verfahren zur kontinuierlichen herstellung von polyamiden, die sich vom p-phenylendiamin ableiten | |
| DE102021209820B4 (de) | Verfahren zur Herstellung eines flüssigen Cellulose-Komposits aus bakterieller Nanocellulose und Carboxymethylcellulose, Cellulose-Komposit und dessen Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |